EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy

Sahar Balkhi iD, Anna Di Spirito, Alessandro Poggi iD, Lorenzo Mortara iD

Cells · 12.02.2025 · 14 (4) · 264

DOI: 10.3390/cells14040264 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.02.2025. Verfasst von Sahar Balkhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Immunotherapy, Immunomodulation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondi di Ateneo per la Ricerca, Università dell'Insubria, Fondi di Ateneo per la Ricerca FAR2023, Fondi di Ateneo per la Ricerca FAR2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia, affecting a significant proportion of the elderly population. AD is characterized by cognitive decline and functional impairments due to pathological hallmarks like amyloid β-peptide (Aβ) plaques and neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau. Microglial activation, chronic neuroinflammation, and disruptions in neuronal communication further exacerbate the disease. Emerging research suggests that immune modulation could play a key role in AD treatment given the significant involvement of neuroinflammatory processes. This review focuses on recent advancements in immunotherapy strategies aimed at modulating immune responses in AD, with a specific emphasis on microglial behavior, amyloid clearance, and tau pathology. By exploring these immunotherapeutic approaches, we aim to provide insights into their potential to alter disease progression and improve patient outcomes, contributing to the evolving landscape of AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseImmunotherapyImmunomodulationHumansAnimalsMicrogliaAmyloid beta-Peptidestau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseasechronic neuroinflammationimmunotherapymicroglial activation

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
  • Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

ORCID-Profile: Sahar Balkhi, Alessandro Poggi, Lorenzo Mortara

Förderung

  • Fondi di Ateneo per la Ricerca, Università dell'Insubria
  • Fondi di Ateneo per la Ricerca FAR2023
  • Fondi di Ateneo per la Ricerca FAR2024

Zitieren

APA

Balkhi, S., Di Spirito, A., Poggi, A., & Mortara, L. (2025). Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy. Cells, 14(4), 264. https://doi.org/10.3390/cells14040264

Vancouver

Balkhi S, Di Spirito A, Poggi A, Mortara L. Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy. Cells. 2025;14(4):264. doi:10.3390/cells14040264

BibTeX
@article{Balkhi2025,
  author = {Balkhi, Sahar and Di Spirito, Anna and Poggi, Alessandro and Mortara, Lorenzo},
  title = {Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {264},
  doi = {10.3390/cells14040264}
}
Kostenlos starten →